Evidence map›Paper›PMID 26515068›Full record

ArticleThe Journal of biological chemistry2016

Selective Activation of Nociceptor TRPV1 Channel and Reversal of Inflammatory Pain in Mice by a Novel Coumarin Derivative Muralatin L from Murraya alata.

Ning-Ning Wei, Hai-Ning Lv, Yang Wu, Shi-Long Yang, Xiao-Ying Sun, Ren Lai, Yong Jiang, KeWei Wang

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Ning-Ning WeiFrom the Department of Neurobiology and Neuroscience Research Institute, School of Basic Medical Sciences, Peking University Health Science Center.
Hai-Ning Lvthe State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191.
Yang Wuthe Department of Molecular and Cellular Pharmacology, IDG/McGovern Institute for Brain Research, Peking University School of Pharmaceutical Sciences, Beijing 100191.
Shi-Long Yangthe Key Laboratory of Animal Models and Human Disease Mechanisms, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, Yunnan, and.
Xiao-Ying Sunthe Department of Pharmacology, Qingdao University School of Pharmacy, Qingdao 266021, China.
Ren Laithe Key Laboratory of Animal Models and Human Disease Mechanisms, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, Yunnan, and.
Yong Jiangthe State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, yongjiang@bjmu.edu.cn.
KeWei WangFrom the Department of Neurobiology and Neuroscience Research Institute, School of Basic Medical Sciences, Peking University Health Science Center, the Department of Molecular and Cellular Pharmacology, IDG/McGovern Institute for Brain Research, Peking University School of Pharmaceutical Sciences, Beijing 100191, the Department of Pharmacology, Qingdao University School of Pharmacy, Qingdao 266021, China wangkw@bjmu.edu.cn.
Peking University · CNChinese Academy of Sciences · CNMcGovern Institute for Brain Research · USQingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coumarin and its derivatives are fragrant natural compounds isolated from the genus Murraya that are flowering plants widely distributed in East Asia, Australia, and the Pacific Islands. Murraya plants have been widely used as medicinal herbs for relief of pain, such as headache, rheumatic pain, toothache, and snake bites. However, little is known about their analgesic components and the molecular mechanism underlying pain relief. Here, we report the bioassay-guided fractionation and identification of a novel coumarin derivative, named muralatin L, that can specifically activate the nociceptor transient receptor potential vanilloid 1 (TRPV1) channel and reverse the inflammatory pain in mice through channel desensitization. Muralatin L was identified from the active extract of Murraya alata against TRPV1 transiently expressed in HEK-293T cells in fluorescent calcium FlexStation assay. Activation of TRPV1 current by muralatin L and its selectivity were further confirmed by whole-cell patch clamp recordings of TRPV1-expressing HEK-293T cells and dorsal root ganglion neurons isolated from mice. Furthermore, muralatin L could reverse inflammatory pain induced by formalin and acetic acid in mice but not in TRPV1 knock-out mice. Taken together, our findings show that muralatin L specifically activates TRPV1 and reverses inflammatory pain, thus highlighting the potential of coumarin derivatives from Murraya plants for pharmaceutical and medicinal applications such as pain therapy.

Indexed as

Amino Acid SequenceAnimalsBinding SitesCalciumCapsaicinCoumarinsGanglia, SpinalHEK293 CellsHumansInflammationIon Channel GatingMagnetic Resonance SpectroscopyMice, Inbred C57BLMice, KnockoutModels, MolecularMolecular Sequence DataCalciumCapsaicinCoumarinsmuralatin LTRPV1 receptorTRPV Cation Channelscalciumcalcium imagingdrug discoverydrug screeningion channelneuronpaintransient receptor potential channels (TRP channels)

Identifiers

PMID26515068
PMCPMC4705384
OpenAlexW2231317968

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.